BB&T Securities LLC reduced its position in shares of Danaher Co. (NYSE:DHR) by 2.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 163,390 shares of the conglomerate’s stock after selling 3,315 shares during the period. BB&T Securities LLC’s holdings in Danaher were worth $16,123,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently added to or reduced their stakes in DHR. Mount Yale Investment Advisors LLC acquired a new position in Danaher in the 1st quarter valued at $103,000. IMS Capital Management acquired a new position in Danaher in the 2nd quarter valued at $107,000. BerganKDV Wealth Management LLC acquired a new position in Danaher in the 2nd quarter valued at $111,000. Braun Bostich & Associates Inc. raised its holdings in Danaher by 506.4% in the 2nd quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock valued at $121,000 after acquiring an additional 1,023 shares in the last quarter. Finally, Kaizen Advisory LLC raised its holdings in Danaher by 150.3% in the 2nd quarter. Kaizen Advisory LLC now owns 1,464 shares of the conglomerate’s stock valued at $144,000 after acquiring an additional 879 shares in the last quarter. 76.95% of the stock is owned by institutional investors and hedge funds.
Several equities analysts have weighed in on DHR shares. Zacks Investment Research cut Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, May 16th. ValuEngine cut Danaher from a “buy” rating to a “hold” rating in a report on Thursday, June 21st. Morgan Stanley boosted their price target on Danaher from $113.00 to $120.00 and gave the stock an “overweight” rating in a report on Friday, July 13th. Bank of America set a $113.00 price target on Danaher and gave the stock a “buy” rating in a report on Thursday, July 19th. Finally, Royal Bank of Canada boosted their price target on Danaher to $107.00 and gave the stock a “positive” rating in a report on Thursday, July 19th. They noted that the move was a valuation call. Two investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Danaher currently has a consensus rating of “Buy” and a consensus price target of $108.31.
In related news, SVP Robert S. Lutz sold 14,555 shares of the business’s stock in a transaction on Tuesday, July 24th. The stock was sold at an average price of $103.93, for a total transaction of $1,512,701.15. Following the sale, the senior vice president now owns 18,044 shares in the company, valued at approximately $1,875,312.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Mitchell P. Rales acquired 1,080 shares of Danaher stock in a transaction that occurred on Tuesday, July 31st. The shares were purchased at an average price of $102.32 per share, for a total transaction of $110,505.60. Following the transaction, the chairman now directly owns 1,827,953 shares in the company, valued at $187,036,150.96. The disclosure for this purchase can be found here. Insiders have sold a total of 299,961 shares of company stock worth $30,619,691 in the last 90 days. 11.90% of the stock is currently owned by corporate insiders.
Danaher stock opened at $104.66 on Friday. The company has a quick ratio of 1.07, a current ratio of 1.50 and a debt-to-equity ratio of 0.41. Danaher Co. has a 52 week low of $83.81 and a 52 week high of $106.08. The firm has a market cap of $73.19 billion, a PE ratio of 24.16, a price-to-earnings-growth ratio of 2.00 and a beta of 1.03.
Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 19th. The conglomerate reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.06. Danaher had a return on equity of 11.55% and a net margin of 13.84%. The company had revenue of $4.98 billion during the quarter, compared to analysts’ expectations of $4.91 billion. During the same quarter in the previous year, the firm earned $0.99 EPS. Danaher’s revenue was up 10.4% on a year-over-year basis. research analysts forecast that Danaher Co. will post 4.49 EPS for the current year.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Recommended Story: Closed-End Mutual Funds (CEFs)
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.